Zobrazeno 1 - 10
of 25
pro vyhledávání: '"N A, Kupryshina"'
Autor:
Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, N. A. Kupryshina, A. G. Zhukov
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 90-103 (2023)
Multiple myeloma is a malignant tumor characterized by the proliferation of clonal plasma cells and currently remains an incurable disease, despite advances in therapy. Resistance and development of double refractoriness represent a significant probl
Externí odkaz:
https://doaj.org/article/2e9274d2ce5440159cbbdfca401a2dad
Autor:
Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, N. A. Kupryshina, T. T. Valiev
Publikováno v:
Онкогематология, Vol 18, Iss 4, Pp 70-77 (2023)
Despite the therapy advances, largely due to the study of molecular biology, multiple myeloma remains an incurable disease, and refractory course or relapses significantly worsen the prognosis. In this regard, the development of effective therapeutic
Externí odkaz:
https://doaj.org/article/3960a0c9a758471985f6a34882d99343
Autor:
Yu. E. Ryabukhina, A. D. Shirin, O. L. Timofeeva, N. N. Tupitsyn, M. A. Frenkel, N. A. Kupryshina, M. A. Volkova
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 31-37 (2022)
Between July 2005and October 2006, eight patients (pts) with hairy cell leukaemia were treated with Vero- cladribine at N.N. Blokhin Cancer Research Center. All pts achieved complete remission (CR). Duration of CR ranges from 1+ to 12+ months in 7 ca
Externí odkaz:
https://doaj.org/article/9d9cb8e84d6349099381d81d3d645393
Autor:
V. E. Syutkin, V. R. Gorodetskiy, A. A. Salienko, N. A. Probatova, N. A. Kupryshina, M. S. Novruzbekov
Publikováno v:
Трансплантология (Москва), Vol 13, Iss 3, Pp 272-279 (2021)
Introduction. One of the serious complications after transplantation of solid organs and bone marrow is the development of post-transplant lymphoproliferative diseases.Clinical case. To evaluate the course of post-transplant lymphoproliferative disea
Externí odkaz:
https://doaj.org/article/e82423111c574422bf36ab46298ca549
Autor:
T. M. Djumanazarov, S. V. Chulkova, N. N. Tupitsyn, O. A. Chernysheva, A. K. Allakhverdiev, A. D. Palladina, N. A. Kupryshina, O. P. Kolbatskaya, P. V. Kononetz, B. B. Akhmedov, S. S. Gerasimov
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 94-99 (2020)
Introduction.Detection of disseminated tumor cells (DTC) in solid tumors is an important component of the assessment of disease prognosis. Bone marrow damage is common. There is evidence indicating an important role for bone marrow lymphocyte subpopu
Externí odkaz:
https://doaj.org/article/6329f428181145198ddeff6efa3dafdf
Autor:
V. I. Vasilyev, I. V. Gaiduk, S. G. Palshina, V. R. Gorodetsky, E. V. Sokol, E. B. Rodionova, M. V. Burtseva, N. S. Shornikova, N. A. Probatova, N. V. Kokosadze, A. I. Pavlovskaya, N. A. Kupryshina, T. N. Safonova
Publikováno v:
Современная ревматология, Vol 13, Iss 1, Pp 44-51 (2019)
Objective: to identify the main types of lymphoma with the onset of involvement of the major salivary glands (MSGs), which are encountered in rheumatologic practice, and to evaluate the efficiency of minimally invasive incisional biopsies of the MSGs
Externí odkaz:
https://doaj.org/article/c7b06a86d3364f728de57bda55452af8
Autor:
Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, A. G. Zhukov, N. A. Kupryshina
Publikováno v:
MD-Onco. 3:61-67
Use of microinfusion elastomeric pumps for extended administration of antitumor drugs improves patients’ quality of life during prolonged cyclic treatment because of the absence of venous complications and infusion allergic reactions during adminis
Autor:
Yu. E. Ryabukhina, F. M. Abbasbeyli, P. A. Zeynalova, O. L. Timofeeva, N. A. Kupryshina, A. G. Zhukov
Publikováno v:
MD-Onco. 2:28-35
Multiple myeloma is a B-cell lymphoproliferative disorder. Morphological substrate of the disorder are plasma cells producing monoclonal immunoglobulin, and the disorder is characterized by heterogeneity of clinical manifestations. Due to the underst
Autor:
Yu. E. Ryabukhina, O. L. Timofeeva, P. A. Zeynalova, F. M. Abbasbeyli, M. V. Antonets, V. E. Gruzdev, M. A. Anisimov, A. A. Akhobekov, N. A. Kupryshina
Publikováno v:
MD-Onco. 2:47-54
Plasma cell leukemia (PCL) is a rare malignant plasma cell neoplasm with aggressive clinical progression, minimal response to therapy and unfavorable prognosis. Concomitant new coronavirus infection COVID-19 and its complications significantly worsen
Autor:
Yu. E. Ryabukhina, O. L. Timofeeva, A. O. Akhov, F. M. Abbasbeyli, P. A. Zeynalova, O. V. Sinitsyna, A. A. Akhobekov, N. A. Kupryshina, A. G. Zhukov
Publikováno v:
MD-Onco. 2:48-57
Multiple myeloma (MM) is a B-cell malignant tumor; its morphological substrate – plasma cells – produces monoclonal immunoglobulin. Primarily, MM is diagnosed in elderly people and is characterized by a variety of clinical manifestations caused b